ScreenerHero
CVCapsoVision Inc. Common Stock
NAS · US · Healthcare · Medical Devices · capsovision.com
5.900USD-3.59%Mkt Cap: 306.29M $P/E: —

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy…

Industry Peers

Medical Devices
Screen all
ABT
Abbott Laboratories
$198.81BUSDP/E 36.9
SYK
STRYKER CORP. R
$120.66BUSDP/E 34.7
SYK
Stryker Corporation
$125.70BUSDP/E 33.9
2M6
Medtronic plc
$111.66BUSDP/E 24.9
BSX
Boston Scientific Corporation
$75.37BUSDP/E 21.1
EW
Edwards Lifesciences Corporation
$53.13BUSDP/E 54.9
SHL
Siemens Healthineers AG
$48.43BUSDP/E 19.9
GEHC
GE HealthCare Technologies Inc. Common Stock
$33.94BUSDP/E 17.2
DXCM
DexCom, Inc.
$33.92BUSDP/E 35.5
PHIA
Koninklijke Philips N.V.
$25.08BUSDP/E 20.7
ZBH
Zimmer Biomet Holdings, Inc.
$19.21BUSDP/E 24.5
SOON
Sonova Holding AG
$16.48BUSDP/E 26.9
PEN
Penumbra, Inc.
$12.87BUSDP/E 80.5
GMED
Globus Medical, Inc.
$11.86BUSDP/E 22.6
GKOS
Glaukos Corp
$11.18BUSD
EUZ
Eckert & Ziegler SE
$10.01BUSDP/E 17.1
PODD
Insulet Corporation
$10.51BUSDP/E 28.4
SN
Smith & Nephew plc
$9.73BUSDP/E 19.8
BIO
Bio-Rad Laboratories, Inc. Class A
$9.75BUSDP/E 44.3
DEMANT
Demant A/S
$8.82BUSDP/E 25.0

Key Statistics

Company
Market Cap306.29M $
Enterprise Value287.39M $
Revenue (TTM)13.89M $
Gross Profit7.17M $
Net Income (TTM)-25.32M $
Revenue/Share0.2910 USD
Last Price5.900 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees99
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-9.72
EV/Revenue20.69
P/S21.29
P/B22.47
EPS (TTM)-1.08
EPS (Forward)—
52W Range
3.43421% of range15.37
52W High15.37 USD
52W Low3.434 USD
Profitability
Gross Margin52.92%
Oper. Margin-208.07%
EBITDA Margin-212.90%
Profit Margin-186.77%
ROE-190.91%
ROA-139.37%
Growth
Revenue Growth9.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.86M $
CapEx (TTM)90.00K $
FCF Margin-117.18%
FCF Yield-5.31%
Net Debt-8.39M $
Net Debt/EBITDA0.28
Balance Sheet
Debt/Equity0.07
Current Ratio3.35
Quick Ratio2.20
Book Value/Sh0.2630 USD
Cash/Share0.1810 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)10.00 USD
Upside (mean)+69.5%
Target Range10.00 USD – 10.00 USD
# Analysts1
Ownership
Shares Out.50.05M
Float31.50M
Insiders32.04%
Institutions10.35%
Short Interest
Short Ratio15.3d
Short % Float5.10%
Short % Out.3.83%
Shares Short1.91M
Short (prev mo.)1.72M
Technical
SMA 506.692 (-11.8%)
SMA 2006.742 (-12.5%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)102.34K
Avg Vol (10d)102.17K
Technical Indicators
RSI (14)39.9
MACD-0.0610
MACD Signal0.0005
MACD Hist.-0.0616
BB Upper7.184 USD
BB Middle6.699 USD
BB Lower6.213 USD
BB Width14.49%
ATR (14)0.4133 USD
Vol Ratio (20d)0.99x